HER2-low metastatic breast cancers: clinic-pathological characteristics, metastatic sites, and survival impact on biomarker discordance.
- DOI
- 10.1007/s00428-026-04710-z
- Published
- 2026 Sep 12
- Container
- Virchows Archiv : an international journal of pathology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00428-026-04710-z,
title = {HER2-low metastatic breast cancers: clinic-pathological characteristics, metastatic sites, and survival impact on biomarker discordance.},
author = {Leung KL and Chan R and Leung H and Li J and Aphivatanasiri C and Ni YB and Tsang JY and Fu ME and Guo D and Tse GM},
year = {2026},
journal = {Virchows Archiv : an international journal of pathology},
doi = {10.1007/s00428-026-04710-z},
url = {https://doi.org/10.1007/s00428-026-04710-z}
}RIS
TY - JOUR TI - HER2-low metastatic breast cancers: clinic-pathological characteristics, metastatic sites, and survival impact on biomarker discordance. AU - Leung KL AU - Chan R AU - Leung H AU - Li J AU - Aphivatanasiri C AU - Ni YB AU - Tsang JY AU - Fu ME AU - Guo D AU - Tse GM PY - 2026 JO - Virchows Archiv : an international journal of pathology DO - 10.1007/s00428-026-04710-z UR - https://doi.org/10.1007/s00428-026-04710-z ER -
APA
KL, L., R, C., H, L., J, L., C, A., YB, N., JY, T., ME, F., D, G., & GM, T. (2026). HER2-low metastatic breast cancers: clinic-pathological characteristics, metastatic sites, and survival impact on biomarker discordance.. Virchows Archiv : an international journal of pathology. https://doi.org/10.1007/s00428-026-04710-z
Source records
- pubmed · retrieved 2026-09-26T06:29:16.119Z